FFA
ZVRA icon

Farther Finance Advisors’s Zevra Therapeutics ZVRA Stock Holding History

Farther Finance Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$856 Sell
78
-150
-66% -$1.78K ﹤0.01% 5627
2026
Q2 		$3.27K Buy
228
+18
+9% +$200 ﹤0.01% 4992
2026
Q1 		$1.98K Buy
210
+184
+708% +$1.66K ﹤0.01% 4902
2025
Q4 		$233 Buy
+26
New +$246 ﹤0.01% 5197

Other funds holding ZVRA

MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's ZVRA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Zevra Therapeutics (ZVRA) stake by 66% in Q3 2026, selling an estimated $1.78K and leaving 78 shares worth $856. The position accounts for ﹤0.01% of the portfolio, ranked #5627.

Farther Finance Advisors first reported a position in ZVRA in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.27K in Q2 2026. 4 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Farther Finance Advisors held 78 shares of Zevra Therapeutics worth $856 as of Q3 2026.
  • Farther Finance Advisors sold 150 Zevra Therapeutics shares in Q3 2026, an estimated $1.78K.
  • Zevra Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5627 holding.
  • Farther Finance Advisors first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Zevra Therapeutics position peaked at $3.27K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.